GHRP-6 CJC-1295 NO DAC Peptide Vial

Product Overview

The GHRP-6 CJC-1295 NO DAC Peptide Vial available at Direct Anti Peptide is a synergistic dual-peptide research blend engineered for advanced in vitro and preclinical investigations into growth hormone axis signalling. GHRP-6 (Growth Hormone Releasing Peptide-6) is a hexapeptide that acts on the ghrelin receptor to stimulate endogenous growth hormone secretion, while CJC-1295 NO DAC is a tetrasubstituted analogue of growth hormone-releasing hormone (GHRH) that amplifies and sustains GH pulse amplitude without the prolonged half-life conferred by a Drug Affinity Complex. When combined in a single sterile vial, these two research peptides exhibit well-documented synergistic activity on the somatotropic axis, making this blend a highly sought-after research tool for scientists studying GH regulation, metabolic signalling, and body composition mechanisms. Buy online today with confidence from Direct Anti Peptide and benefit from our quality-first fulfilment process.

Peptide Structure & Amino Acid Sequence

GHRP-6 is a synthetic hexapeptide with the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂. Its incorporation of D-amino acids confers enhanced enzymatic resistance compared with native peptides. CJC-1295 NO DAC (also referred to as Mod GRF 1-29) is derived from the first 29 amino acids of endogenous GHRH, incorporating four strategic amino acid substitutions — at positions 2, 8, 15, and 27 — that collectively improve receptor binding affinity and resistance to proteolytic degradation while preserving a pharmacokinetic profile suitable for pulsatile research protocols. The absence of the Drug Affinity Complex (DAC) moiety means this analogue does not covalently bind to albumin, resulting in a shorter active window that more closely mirrors physiological GH pulse patterns — a distinction of significant interest to researchers designing time-course studies.

Chemical & Physical Characteristics

• Blend composition (2.5 mg vial): CJC-1295 NO DAC 0.8 mg | GHRP-6 1.7 mg
• Blend composition (10 mg vial): CJC-1295 NO DAC 5 mg | GHRP-6 5 mg
• Appearance: White to off-white lyophilized powder
• Molecular Formula (GHRP-6): C₄₆H₅₆N₁₂O₆
• Molecular Weight (GHRP-6): ~873.0 Da
• Molecular Formula (CJC-1295 NO DAC): C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight (CJC-1295 NO DAC): ~3367.9 Da
• Solubility: Soluble in sterile aqueous buffers; handle under standard laboratory conditions
• Storage temperature: −20 °C (lyophilized); protect from light and moisture

Purity & Analytical Verification (HPLC & MS)

Every batch of the GHRP-6 CJC-1295 NO DAC Peptide Vial produced for Direct Anti Peptide is subject to rigorous analytical testing. Purity is verified at ≥98% by reverse-phase high-performance liquid chromatography (RP-HPLC), and molecular identity is confirmed by mass spectrometry (MS). These dual analytical methods ensure that each vial delivered to your laboratory contains peptide material of the highest achievable purity, free from synthesis by-products, truncated sequences, or residual reagents that could compromise experimental reproducibility.

Quality Control & Lyophilization Integrity

The blend is co-lyophilized under controlled freeze-drying conditions to produce a homogeneous, stable powder that maintains peptide integrity throughout transit and storage. Each sterile glass vial is sealed under inert gas and capped to prevent moisture ingress and oxidative degradation. Batch-level certificates of analysis (CoA) documenting HPLC purity traces and MS confirmation data are available upon request, providing full traceability for your research records.

Safety, Handling & Laboratory Precautions

This product is classified as a research chemical and must be handled exclusively by trained laboratory professionals in appropriately equipped research facilities. Standard personal protective equipment (PPE) — including nitrile gloves, safety glasses, and a laboratory coat — should be worn at all times during handling. Researchers should consult applicable institutional biosafety guidelines and relevant safety data sheets before commencing work. This product is not approved for, nor intended for, any form of human or animal administration.

Reconstitution, Packaging & Storage

The lyophilized blend should be reconstituted using a suitable sterile aqueous solvent appropriate for the intended in vitro research application. All reconstitution procedures must be performed under aseptic laboratory conditions using calibrated equipment. Vials should be stored at −20 °C in the lyophilized state and shielded from direct light. Once reconstituted, the solution should be aliquoted as required and stored according to established laboratory protocols for peptide solutions. Packaging is designed to maintain sterility and product integrity during shipping and storage.

Intended Research Use & Market Positioning

The GHRP-6 CJC-1295 NO DAC blend is positioned as a premium dual-peptide research tool for scientists and institutions investigating growth hormone axis biology, metabolic regulation, neuroendocrine signalling, and related fields. Its synergistic receptor activity profile makes it particularly valuable for studies examining GH pulse dynamics, somatotropic feedback mechanisms, and the comparative pharmacology of GHRP and GHRH-class peptides. Researchers looking to buy a high-purity, analytically verified GH-axis peptide blend will find this product competitively priced and reliably available at Direct Anti Peptide.

Ordering, Availability & Fulfillment

Direct Anti Peptide offers the GHRP-6 CJC-1295 NO DAC Peptide Vial for sale in multiple quantity formats to accommodate both pilot studies and extended research programmes. Order now through our secure eCommerce platform and benefit from fast dispatch, discreet laboratory-grade packaging, and responsive customer support. We maintain consistent stock levels to ensure your research is never delayed. All orders are fulfilled with accompanying documentation to support your laboratory procurement records.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. This product has not been evaluated or approved by any regulatory authority for therapeutic, prophylactic, or diagnostic use in humans or animals. It must be purchased, stored, and used in strict accordance with all applicable local, national, and international laws and regulations governing research chemicals. Direct Anti Peptide assumes no liability for misuse, improper handling, or use outside the scope of legitimate scientific research. By purchasing this product, the buyer confirms that they are a qualified research professional and that the product will be used solely for lawful in vitro or preclinical research purposes.